41 related articles for article (PubMed ID: 12225895)
1. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis.
Reddy J; Illes Z; Zhang X; Encinas J; Pyrdol J; Nicholson L; Sobel RA; Wucherpfennig KW; Kuchroo VK
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15434-9. PubMed ID: 15492218
[TBL] [Abstract][Full Text] [Related]
2. Association of Autophagy in the Cell Death Mediated by Dihydrotestosterone in Autoreactive T Cells Independent of Antigenic Stimulation.
Jia T; Anandhan A; Massilamany C; Rajasekaran RA; Franco R; Reddy J
J Neuroimmune Pharmacol; 2015 Dec; 10(4):620-34. PubMed ID: 26416183
[TBL] [Abstract][Full Text] [Related]
3. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.
Matarese G; Carrieri PB; La Cava A; Perna F; Sanna V; De Rosa V; Aufiero D; Fontana S; Zappacosta S
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5150-5. PubMed ID: 15788534
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kiptoo P; Kobayashi H; Ridwan R; Brocke S; Siahaan TJ
Clin Immunol; 2008 Oct; 129(1):69-79. PubMed ID: 18676182
[TBL] [Abstract][Full Text] [Related]
5. PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity.
Amici SA; Osman W; Guerau-de-Arellano M
Front Immunol; 2021; 12():695947. PubMed ID: 34168658
[TBL] [Abstract][Full Text] [Related]
6. E-WE thrombin, a protein C activator, reduces disease severity and spinal cord inflammation in relapsing-remitting murine experimental autoimmune encephalomyelitis.
Verbout NG; Su W; Pham P; Jordan K; Kohs TC; Tucker EI; McCarty OJ; Sherman LS
Res Sq; 2023 Apr; ():. PubMed ID: 37131631
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
Monson NL; Cravens P; Hussain R; Harp CT; Cummings M; de Pilar Martin M; Ben LH; Do J; Lyons JA; Lovette-Racke A; Cross AH; Racke MK; Stüve O; Shlomchik M; Eagar TN
PLoS One; 2011 Feb; 6(2):e17103. PubMed ID: 21359213
[TBL] [Abstract][Full Text] [Related]
8. Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis.
Verbout NG; Su W; Pham P; Jordan KR; Kohs TCL; Tucker EI; McCarty OJT; Sherman LS
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C40-C49. PubMed ID: 37955120
[TBL] [Abstract][Full Text] [Related]
9. Effects of biological sex and pregnancy in experimental autoimmune encephalomyelitis: It's complicated.
McCombe PA; Greer JM
Front Immunol; 2022; 13():1059833. PubMed ID: 36518769
[TBL] [Abstract][Full Text] [Related]
10. TGFB1-Mediated Gliosis in Multiple Sclerosis Spinal Cords Is Favored by the Regionalized Expression of HOXA5 and the Age-Dependent Decline in Androgen Receptor Ligands.
Nataf S; Guillen M; Pays L
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779094
[TBL] [Abstract][Full Text] [Related]
11. Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma.
Lambert WS; Carlson BJ; Formichella CR; Sappington RM; Ahlem C; Calkins DJ
Front Neurosci; 2017; 11():45. PubMed ID: 28223915
[TBL] [Abstract][Full Text] [Related]
12. Molecular targets for 17α-ethynyl-5-androstene-3β,7β,17β-triol, an anti-inflammatory agent derived from the human metabolome.
Reading CL; Frincke JM; White SK
PLoS One; 2012; 7(2):e32147. PubMed ID: 22384159
[TBL] [Abstract][Full Text] [Related]
13. Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.
Ahlem CN; Kennedy MR; Page TM; Reading CL; White SK; McKenzie JJ; Cole PI; Stickney DR; Frincke JM
Int J Clin Exp Med; 2011; 4(2):119-35. PubMed ID: 21686136
[TBL] [Abstract][Full Text] [Related]
14. Phase I and Phase II clinical trials of androst-5-ene-3β,7β,17β-triol.
Stickney DR; Ahlem CN; Morgan E; Reading CL; Onizuka N; Frincke JM
Am J Transl Res; 2011 May; 3(3):275-83. PubMed ID: 21633633
[TBL] [Abstract][Full Text] [Related]
15. 5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice.
Nicoletti F; Auci DL; Mangano K; Flores-Riveros J; Villegas S; Frincke JM; Reading CL; Offner H
Autoimmune Dis; 2010 May; 2010():757432. PubMed ID: 21188238
[TBL] [Abstract][Full Text] [Related]
16. HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.
Conrad D; Wang A; Pieters R; Nicoletti F; Mangano K; van Heeckeren AM; White SK; Frincke JM; Reading CL; Stickney D; Auci DL
J Inflamm (Lond); 2010 Oct; 7():52. PubMed ID: 21034489
[TBL] [Abstract][Full Text] [Related]
17. Gender and sex hormones in multiple sclerosis pathology and therapy.
Nicot A
Front Biosci (Landmark Ed); 2009 Jan; 14(12):4477-515. PubMed ID: 19273365
[TBL] [Abstract][Full Text] [Related]
18. A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
Offner H; Zamora A; Drought H; Matejuk A; Auci DL; Morgan EE; Vandenbark AA; Reading CL
J Neuroimmunol; 2002 Sep; 130(1-2):128-39. PubMed ID: 12225895
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
